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Abstract 
A genetic polymorphism within the gene encoding the pituitary adenylate cyclase- activating 
polypeptide (PACAP) receptor type I (PAC1R) has recently been associated with hyper-
reactivity to threat-related cues in women, but not men, with post-traumatic stress disorder 
(PTSD). PACAP is a highly conserved peptide, whose role in mediating adaptive physiological 
stress responses is well established. Far less is understood about the contribution of PACAP 
signaling in emotional learning and memory, particularly the encoding of fear to discrete cues. 
Moreover, a neurobiological substrate that may account for the observed link between PAC1R 
and PTSD in women, but not men, has yet to be identified. Sex differences in PACAP signaling 
during emotional learning could provide novel targets for the treatment of PTSD. Here we 
investigated the contribution of PAC1R signaling within the prefrontal cortex to the acquisition 
of cued fear in female and male rats. We used a variant of fear conditioning called trace fear 
conditioning, which requires sustained attention to fear cues and depends on working-memory 
like neuronal activity within the prefrontal cortex. We found that cued fear learning, but not 
spatial working memory, was impaired by administration of a PAC1R antagonist directly into 
the prelimbic area of the prefrontal cortex. This effect was specific to females. We also found 
that levels of mRNA for the PAC1R receptor in the prelimbic cortex were greater in females 
compared with males, and were highest during and immediately following the proestrus stage 
of the estrous cycle. Together, these results demonstrate a sex-specific role of PAC1R 
signaling in learning about threat-related cues. 
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1. Introduction 
Women are more than twice as likely as men to develop post-traumatic stress disorder 
(PTSD), yet the neurobiological basis of this sex difference is unknown (Kessler et al., 1995, 
Kilpatrick et al., 2013). Recently, dysregulation of pituitary adenylate cyclase-activating 
polypeptide (PACAP) signaling has been implicated in PTSD selectively in women (Ressler 
et al., 2011). Elevated PACAP blood levels and a single nucleotide polymorphism (SNP) in the 
PACAP receptor type-1 (PAC1R) gene are associated with hyperarousal symptoms in women 
but not men with PTSD (Ressler et al., 2011). The SNP is located within an estrogen response 
element of the gene and interferes with DNA binding of an estradiol-ERα complex, which 
suggests a link between ovarian hormones and altered PAC1R expression in these patients 
(Mercer et al., 2016). PACAP is a highly-conserved peptide important for mediating adaptive 
physiological stress responses, and alterations in PACAP signaling may contribute to the 
development or maintenance of PTSD in women (Hammack and May 2015). PACAP may also 
contribute to PTSD by modulating the formation of emotional memories. PACAP and its 
receptors are widely distributed throughout the central nervous system, including areas 
important for memory such as the hippocampus, amygdala, cingulate and frontal cortices, and 
thalamus (for a review see Vaudry et al., 2009). This raises the possibility that PACAP 
signaling may normally contribute to fear memory encoding in these areas. Indeed, the PAC1R 
genetic polymorphism is associated with increased reactivity of fear circuitry to threat-related 
cues and impaired discrimination of threat and safety cues in women with PTSD (Ressler 
et al., 2011, Stevens et al., 2014). Currently, very little is known about the neurobiology of 
PACAP signaling in emotional learning, especially cued fear learning. Preclinical studies 
suggest that PACAP signaling influences contextual fear memory. Mice lacking the PAC1R 
either globally or in the hippocampus and neocortex showed impaired contextual fear 
conditioning (Otto et al., 2001). PACAP delivered intracerebroventricularly in rats enhanced the 
consolidation of a passive avoidance memory at low doses (Sacchetti et al., 2001) and 
temporarily impaired contextual fear memory at high doses (Meloni et al., 2016). PACAP 
delivered directly into the hippocampus enhanced the consolidation of a contextual fear 
memory (Schmidt et al., 2015). Endogenous PACAP may also contribute to the consolidation 
of contextual fear memory given that blocking the activation of the PAC1R with the antagonist 
PACAP6-38 in the hippocampus or the amygdala attenuated the consolidation of contextual 
fear memory (Schmidt et al., 2015). With the exception of the Schmidt et al. study, the 
contribution of PAC1R signaling in individual brain regions to learning has not been explored. 
The prefrontal cortex in particular warrants closer investigation. Dysfunction within prefrontal 
cortical regions in humans is associated with aberrant cognitive and emotional regulation in 
PTSD, including heightened reactivity to threat-related stimuli, possibly through interaction with 
the amygdala (Fani et al., 2012, Shin et al., 2006, Taylor and Whalen, 2015). Moreover, 
abnormal activity in dorsal prefrontal cortical areas may even be a predisposing factor in the 
development of PTSD (Admon et al., 2013). 
Here we tested the contribution of PAC1R signaling in the prefrontal cortex to memory 
formation using trace fear conditioning in female and male rats. Unlike standard cued fear 
conditioning, the trace variant of fear conditioning critically depends on the prefrontal cortex, 
which makes this variant useful for probing prefrontal contributions to emotional learning that 
may be altered in pathological fear and anxiety (Gilmartin et al., 2013b, Gilmartin et al., 2014, 
Gilmartin and Helmstetter, 2010, Guimarais et al., 2011). In trace fear conditioning, subjects 
learn to anticipate a shock that is delivered several seconds after a cue presentation. 
Successful acquisition is associated with sustained attention and prefrontal firing to the cue 
during the stimulus-free trace interval before the shock is delivered – a working-memory like 
function that depends on the dorsomedial prefrontal cortex in rats (Baeg et al., 2001, Gilmartin 
and McEchron, 2005, Gilmartin et al., 2013b, Han et al., 2003). We tested the importance of 
PAC1R in trace conditioning and spatial working memory using direct injections of PACAP6-38 
into the prelimbic (PL) cortex. PAC1R is the primary target of this peptide in the PL given the 
apparent lack of vasoactive intestinal peptide receptor type-2 (VPAC2R) in rodent frontal 
cortices (Lein et al., 2007, Sheward et al., 1995, Usdin et al., 1994). Importantly, we conducted 
this study using both female and male rats. Preclinical studies of PACAP's role in memory 
have been limited to male subjects. However, the sex-specific link between the genetic 
polymorphism in the PAC1R gene in humans and PTSD demands the inclusion of female 
subjects in preclinical studies. We found that the administration of the PAC1R antagonist 
PACAP6-38 into the PL prior to conditioning attenuated the formation of cued fear memory in 
females, but not males. In contrast, the performance of a spatial working memory task was 
unaffected by PACAP6-38. Interestingly, females had significantly higher levels of mRNA for the 
PAC1R within the PL compared with males. These results show that PAC1R signaling within 
the prelimbic cortex has sex specific effects on the formation of cued fear memory and suggest 
that differences in PAC1R transcripts may contribute to this sex difference. 
2. Materials & methods 
2.1. Subjects and surgery 
Adult female (Experiments 1, 2, and 4) and male (Experiments 3 and 4) Long-Evans rats 
(225 g females; 325 g males; Envigo, Indianapolis, IN.) were used in this study. Rats were 
housed individually and received food and water ad libitum. All procedures were in accordance 
with the National Institutes of Health guidelines and approved by the Marquette University 
Institutional Animal Care and Use Committee. After three days of handling, rats in Experiments 
1-3 underwent cannula-implantation surgery under isoflurane anesthesia (1%-2% isoflurane in 
100% O2). Peri-operative pain was managed with daily administration of carprofen in an edible 
supplement (5 mg/kg in MediGel® CPF; ClearH2O, Westbrook, ME) the day before, the day of, 
and the day after surgery. During surgery, the rat's head was shaved and then secured in a 
stereotax (David Kopf, Tujunga, CA). A midline incision was made in the scalp and fascia 
retracted to expose the skull. Small craniotomies were drilled above the target sites and 
stainless steel guide cannulae (26 ga; Plastics One, Roanoke, VA) were stereotaxically 
lowered to the prelimbic (PL) region of the medial prefrontal cortex at a 14° angle (AP +3.2, 
ML ± 1.6, DV -3.2 mm from the skull). The cannulae were secured to the skull with dental 
cement and stainless steel skull screws. Dummy cannulae (33 ga) were inserted into the guide 
cannulae to prevent clogging. Rats recovered in their home cages for a minimum of seven 
days before the experiment began. 
2.2. Drug injections 
As described previously, following recovery from surgery, rats were acclimated to transport 
from their home cage to the procedure room over three consecutive days (Gilmartin et al., 
2012). During this time, the rats were acclimated to gentle restraint in a towel and to the sound 
of the infusion pump that would be used for intracranial injections. On the third day of 
acclimation, rats received mock injections in that the injection cannulae were lowered into the 
guide cannulae, but no drug was delivered. PACAP6-38 was obtained from AnaSpec (Fremont, 
CA) and dissolved in 0.9% sterile saline on the day of injection. On the day of conditioning, rats 
received bilateral injections of the PAC1R antagonist PACAP6-38 (0.5 μL/side; females received 
1 mM, 2 mM, or 3 mM, and males received 2 mM or 3 mM) or sterile saline vehicle (0.5 μL/side) 
into the PL 1 h prior to training. These doses of PACAP6-38 were chosen to fall within the rather 
wide range (0.1 mM–8.8 mM) used in the literature to attenuate endogenous or exogenous 
PACAP directly in the BNST, amygdala, or hypothalamus (Farnham et al., 2012, Missig et al., 
2014, Resch et al., 2011, Roman et al., 2014). The drug was infused at a rate of 0.5 μL per 
minute (Gilmartin and Helmstetter, 2010, Gilmartin et al., 2012). Injectors were left in place for 
90 s after injection to allow the drug to completely diffuse away from the cannula. Rats were 
then returned to their home cages between injection and training. 
2.3. Treatment conditions and group sizes 
For Experiment 1, 48 female rats were run in two cohorts (cohort 1: Saline, 1 mM and 2 mM 
PACAP6-38; cohort 2: Saline, 2 mM and 3 mM PACAP6-38; n = 8-9/group/cohort). One saline-
injected rat was excluded from all analyses due to very high baseline freezing (>70%) in the 
novel testing chamber. This level was greater than 2 standard deviations of the mean. One rat 
was removed from the 1 mM PACAP6-38 group after histological analysis (see Results). There 
was no effect of replication on the data from the groups common to both runs (i.e., Saline and 
2 mM PACAP6-38; ps > 0.37), therefore all data was combined for analysis using the following 
final group sizes: Saline, n = 15; 1 mM PACAP6-38, n = 7; 2 mM PACAP6-38, n = 16; 3 mM 
PACAP6-38, n = 9). 
For Experiment 2, a subset of female rats (n = 11) from cohort 2 underwent delayed alternation 
training and testing (drug history: n = 4, Saline; n = 7, PACAP6-38 2 mM). All rats received 
additional injections of saline, 2 mM PACAP6-38, and muscimol during the course of testing (see 
section 2.5). 
For Experiment 3, 40 male rats were run in two cohorts (cohort 1: Saline, 2 mM PACAP6-38; 
cohort 2: Saline, 3 mM PACAP6-38; n = 10 per group/cohort). Two saline-injected rats were 
excluded from all analyses due to very high baseline freezing (>70%; >2 sd of the mean) in the 
novel testing chamber. One of these two rats was also excluded based on tissue damage at 
the cannula site (see Results). There was no effect of replication on the data from the control 
group common to both runs (i.e., Saline; ps > 0.45), therefore all data was combined for 
analysis using the following final group sizes: Saline, n = 18; 2 mM PACAP6-38, n = 10; 3 mM 
PACAP6-38, n = 10). 
2.4. Fear conditioning 
Training and testing were conducted as previously described (Gilmartin et al., 2012, Gilmartin 
et al., 2013b). During training, rats were placed in Med Associates (St. Albans, VT) 
conditioning chambers (internal dimensions: 30.5 × 24.1 × 29.2 cm), housed in a sound 
attenuating outer chamber and illuminated with a 7.5-W white incandescent lamp attached to 
the outer chamber. Ventilation fans in the outer chamber provided 55-60 dB background noise 
and the auditory cue was delivered through a speaker centered in one side wall of the 
conditioning chamber. Stainless steel bars (4.8 mm diameter, spaced 16 mm apart) on the floor 
of the chamber served to deliver a scrambled footshock. The chamber was cleaned and 
scented with 5% ammonium hydroxide before training each rat. The training session (Fig. 1a) 
consisted of a 6-min baseline period, followed by 6 pairings of a 10-s white noise conditional 
stimulus (CS; 72 dB) and a 1-s footshock unconditional stimulus (UCS; 0.8 mA). The CS offset 
and UCS onset were separated by an empty 20-s trace interval and the intertrial interval (ITI) 
was 240 ± 20 s. 
During training, rats learn to associate both the auditory CS and the training context with the 
shock UCS. Rats were tested for memory of each association separately the day after training. 
Conditional freezing to the CS was tested in a novel chamber (internal dimensions: 
30.5 × 24.1 × 29.2 cm) housed in a sound attenuating outer chamber with 55–60 dB 
background noise. Testing chambers were in a separate room and differed from the training 
chambers in illumination (infrared house lamp), texture (solid, textured floor), and odor (5% 
acetic acid solution). In addition, transport between the colony room and the testing room was 
altered from that used for training: rats were covered during transport and an alternate route 
was used. In trace conditioning, subjects exhibit conditional responses to CS-offset in addition 
to the CS itself (Buhusi and Meck, 2000). Thus, the CS retention test was designed to 
measure rats' fear to both the CS and CS-offset (Gilmartin et al., 2012). This test consisted of 
a 2-min pre-CS baseline period followed by a single 10-s CS (same duration as was used in 
the conditioning procedure). This CS was followed by a 2-min stimulus-free period (SFP) to 
assess freezing in response to CS-offset. After this 2-min period, the CS was presented for 
5 min to assess freezing in response to the CS. Contextual fear memory was assessed by 
measuring conditional freezing during a 10-min re-exposure to the original training chamber. 
2.5. Delayed alternation 
The delayed alternation paradigm is a spatial working memory task, which depends on intact 
prefrontal cortical function (Wang and Cai, 2006). This task typically uses delay periods in the 
range of 5–60 s (Wang and Cai, 2006, Zahrt et al., 1997), which overlaps with the trace interval 
duration used in Experiment 1. Therefore, in Experiment 2 we used delayed alternation with a 
20-s delay to test the contribution of PAC1R to spatial working memory. The training protocol 
used here is adapted from previous reports (Berridge et al., 2006, Zahrt et al., 1997). A subset 
of females (n = 11) from cohort 2 in Experiment 1 were food-restricted to maintain 88-93% of 
their free-feeding body weight; rats were fed 9-10 g of standard lab chow (Teklad rodent diet 
#8604; Envigo, Indianapolis, IN) once daily. Once testing began, food was given 1 h after 
testing. Rats were trained in a T-maze with opaque black floors and walls (overall dimensions: 
81 cm wide x 89 cm long; runway: 19 cm wide x 30 cm tall). Prior to training, rats were 
introduced to food reward (Chocolate Cheerios® General Mills, Minneapolis, MN) and 
habituated to the T-maze for 2 days. During these sessions, rats were allowed to freely explore 
the maze for 10 min with the Cheerios® dispersed throughout the maze. Following habituation, 
rats were trained in an alternation task with a minimal intertrial delay (<10 s), 8-12 trials per 
day. On the first trial, both arms were baited at the end of the arm. On all subsequent trials, 
rats were rewarded with ½ pieces of Cheerios® for choosing the arm not chosen on the 
previous trial. After approximately one week of training, the intertrial delay was increased to 
20 s and rats were trained with 12 trials per day. During the delay, rats were placed in a 
separate holding cage and returned to the start box 5 seconds before the end of the delay. 
Training continued until rats reached criterion performance, which was defined as >60-70% 
correct choices for two consecutive days with <10% difference between days (Berridge et al., 
2006). Once all rats reached criterion (<7 days), bilateral injections of 2 mM PACAP6-38 (0.5 
μL/side) were administered to the PL 1 h prior to testing. An injection of saline vehicle (0.5 
μL/side; 30 min pre-test) was given four days later, followed by a second injection of 2 mM 
PACAP6-38 the next day. Lastly, after 1-2 drug-free testing days, rats received one final drug 
session, in which the GABAA agonist muscimol (1 μg/μL; 0.5 μL/side; MP Biomedicals, Santa 
Ana, CA) was administered 30 min prior to testing. This served as a positive control for the 
prefrontal-dependence of our protocol. 
2.6. Quantitative RT-PCR 
Twenty female rats and 20 male rats were used in Experiment 4 to quantify the relative 
expression of PAC1R (ADCYAP1R1) and PACAP (ADCYAP1) mRNA in the PL cortex. All rats 
were handled for 14 days, followed by 3 consecutive days of transport to the training rooms. 
Half of the rats (n = 10/sex) received a single session of trace fear conditioning as described 
above. Ninety minutes after the end of training, the rats were rapidly decapitated, and 1 mm 
bilateral punches of the PL cortex were collected and flash frozen in liquid nitrogen. The 
remaining rats (n = 10/sex) served as untrained home cage controls and were sacrificed for 
tissue collection time-matched to the fear-conditioned rats. Total RNA was extracted from the 
tissue samples using the MasterPure Complete DNA & RNA Purification Kit (Epicentre; 
Madison, WI). Assessment of RNA purity and quantity was performed on a NanoDrop One 
spectrophotometer (Thermo Scientific, Waltham, MA). Single stranded cDNA synthesis was 
conducted with 1 μg of total RNA using the Promega Reverse Transcription System (Madison, 
WI). Real-time quantitative PCR was performed using the QuantStudio 3 real-time PCR 
system (Applied Biosystems; Carlsbad, CA) with PerfeCTa SYBR Green FastMix containing 
ROX (Quanta Biosciences; Gathersberg, MD). Relative quantification of target gene 
expression was normalized to the reference gene glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) using the ΔΔCt method (Schmittgen and Livak, 2008). The primers were designed to 
be intron-spanning and lack secondary structures using the online primer design tools Primer3 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) and Oligo Calc 
(http://biotools.nubic.northwestern.edu/OligoCalc.html). The primers were as follows: PAC1R 
forward- 5′ TGC CTG TGG CTA TTG CTA TG 3′; PAC1R reverse- 5′ TTT AGT CCC ATC AGG 
TCG TTG 3′; PACAP forward-5′ AAC CCG CTG CAA GAC TTC TA 3′; PACAP reverse- 5′ CTT 
TGC GGT AGG CTT CGT TA 3′; GAPDH forward- 5′ CTC CCA TTC TTC CAC CTT TGA 3′; 
GAPDH reverse- 5′ ATG TAG GCC ATG AGG TCC AC 3′. A single, unique product from 
amplification was confirmed by melt curve analysis, which along with in silico BLAST analysis 
confirmed target specificity. Amplification efficiency of all genes was approximately 95%. 
2.7. Estrous cycle tracking 
The stage of the estrous cycle was determined through daily vaginal lavages of the 20 females 
in Experiment 4. The males in this experiment were handled for approximately the same 
amount of time each day. At approximately the same time each day (10:00 a.m. ± 1 h), the 
females were lightly restrained and 120 μL of deionized water was used to flush the vaginal 
canal and obtain loose vaginal cells. Samples were expelled onto slides, allowed to dry, and 
stained using a Papanicolaou stain (Hubscher et al., 2005). Each stage of the estrous cycle 
was determined with a light microscope using a standard protocol (Hubscher et al., 2005). 
Briefly, the following characteristics were used: proestrus is marked by nucleated basophilic 
cells, estrus is marked by enucleated cornified squamous cells, metestrus is marked by 
clumped, enucleated and nucleated cells and leukocytes, and diestrus is marked by mucus 
and waning leukocytes. Transitions between stages were identified using detailed analysis of 
cellular morphology and composition (Montes and Luque, 1988, Paccola et al., 2013). We 
used these transitions to more accurately predict circulating estradiol (E2) levels and the 
dynamic interaction of E2 and PAC1R in cycling females (Butcher et al., 1974). Females were 
ordered in terms of their cycle stage at tissue collection and classified as High-E2 or Low-E2. 
High-E2 included females in the transition from diestrus to proestrus through the transition 
from proestrus to early estrus (Montes and Luque, 1988, Paccola et al., 2013). Low-E2 
included females in late estrus through diestrus. Cycle stage was assessed for at least five 
days prior to training to ensure rats were cycling regularly. 
2.8. Analyses 
Freezing was defined as the cessation of all movement except that needed for respiration and 
was used as the measure of conditional fear during all training and testing sessions (Fanselow 
and Bolles, 1979). Freezing was scored automatically using FreezeScan 2.0 (CleverSys; 
Reston, VA). Scoring parameters were chosen to produce scores that match hand-scored 
results, conducted by a trained observer (r = 0.99). All statistical analyses were performed with 
Statistica version 13 (Statsoft, Tulsa, OK). Group differences in freezing were analyzed using 
one-way Analysis of Variance (ANOVA)s for context retention and mixed model ANOVAs with 
repeated measures for acquisition and CS retention. Mixed model ANOVAs varied a between-
subjects factor of Group (PACAP6-38 vs Saline) across a within-subjects factor of Period (for 
acquisition: Baseline, Trials 1 through 6, for CS retention: Baseline and CS). We typically 
analyze only the first 2 min of the CS when conditional responding is strongest and to 
temporally match baseline (Gilmartin et al., 2012, Gilmartin et al., 2013b) (Experiments 1 and 
3), but in this study we also analyzed freezing across all 5 min to examine potential sex 
differences in the expression of learned fear (see Results and Fig. 4). For delayed alternation, 
the number of correct choices on injection days was converted to a change score based on the 
3-day baseline period before any drugs were administered (Berridge et al., 2006). Change 
scores from both PACAP6-38 injection days were averaged together. These scores were 
analyzed using repeated measures ANOVA. Fisher's least significant difference tests were 
used to make pairwise comparisons when ANOVAs revealed an appropriate significant main 
effect or interaction. Effect sizes were calculated using Cohen's d. An α level of 0.05 was 
required for significance in all analyses. 
PAC1R and PACAP mRNA levels were referenced to GAPDH and expressed as a fold-change 
relative to a control condition prior to analysis. One male sample from the home cage control 
group was an outlier (PAC1R mRNA > 2 standard deviations from the mean of all males 
tested) and was eliminated from the analyses. In addition, samples which failed to produce 
reliable plate readings were excluded from analysis (PAC1R: 2 females, 0 males; PACAP: 2 
females, 2 males). 
2.9. Histology 
At the end of Experiments 1-3, rats were deeply anesthetized with concentrated isoflurane in a 
narcosis chamber, transcardially perfused with 0.1M phosphate-buffered saline followed by 
10% buffered formalin, and the brains were placed in fixative overnight. The following day, 
brains were transferred to a 30% sucrose solution (in 0.1M phosphate buffer) for 
cryoprotection. Brains were then frozen, sectioned coronally, mounted on glass slides, and 
stained with cresyl violet. Cannula placement was assessed with light microscopy. 
3. Results 
3.1. Experiment 1: prefrontal PAC1R and fear learning in females 
All forty-eight female rats implanted with bilateral cannulae had successful placements in the 
PL. Placements for the Saline and PACAP6-38 2 mM dose groups are shown in Fig. 1b. One rat 
was excluded from all analyses due to having some tissue damage at the injection site 
(PACAP6-38 1 mM group). 
 
Fig. 1. Experimental timeline and prelimbic cannula placements. (a) PL injections of Saline or PACAP6-
38 were given 1 h prior to training, and memory retention was assessed the following day in the absence 
of drug. Trace fear conditioning consisted of six CS-UCS pairings, in which the offset of the CS and 
onset of the UCS were separated by 20 s. (b) Cannula placements for females and males treated with 
Saline (open symbols) or 2 mM PACAP6-38 (closed symbols). Placements for 1 mM (females) and 3 mM 
(females and males) PACAP6-38 rats were within this range. Coronal diagrams were adapted from 
Paxinos and Watson (2007) with permission from Elsevier. 
Pre-training injection of the PAC1R antagonist PACAP6-38 impaired the formation of cued, but 
not contextual fear memory (Fig. 2). The administration of PACAP6-38 did not affect the within-
session acquisition or expression of freezing during the training session (Fig. 2a). Each 
comparison revealed a significant main effect of Trial (Fs > 45; ps < 0.00001), but no main 
effect of Drug (ps > 0.08) or Drug x Trial interaction (ps > 0.18). During the CS presentation in a 
novel chamber the day after training, rats in the 2 mM PACAP6-38 group exhibited less freezing 
compared with Saline-injected controls (Fig. 2b). This observation was supported by a 
significant Drug x Period interaction (F(1, 29) = 5.632, p = .024). Planned comparisons confirmed 
that PACAP6-38 rats exhibited significantly less freezing during the CS than the control rats 
(p = .007; Cohen's d: 0.84). Rats which had been injected with 3 mM PACAP6-38 showed a 
trend for a Drug main effect during the CS test (F(1, 22) = 3.421, p = .078; Cohen's d: 0.82). In 
contrast, rats injected with 1 mM PACAP6-38 did not show an impairment in conditional fear 
memory compared with vehicle control rats: there was neither a main effect of Drug nor a Drug 
x Period interaction (ps > 0.28). Contextual fear memory was unaffected by pre-training 
administration of PACAP6-38 (Fig. 2c; all ps > 0.13). Freezing to CS-offset measured in the SFP 
of the CS test (data not shown) was largely unaffected as well. While rats injected with the low 
dose of PACAP6-38 did exhibit greater freezing at CS-offset compared with controls 
(91.6% ± 3.86% s.e.m. (1 mM PACAP6-38) vs. 65.06% ± 7.92% s.e.m. (Saline); main effect of 
Drug (F(1, 20) = 8.014, p = .01), neither of the two higher doses affected CS-offset freezing. 
Together, these results suggest that pre-training PACAP6-38 in the prefrontal cortex selectively 
impairs the formation of memory for the CS-UCS association while leaving the acquisition of 
contextual fear intact. 
 
Fig. 2. PACAP6-38 dose-dependently impaired the formation of cued, but not contextual, fear memory in 
females. (a) All subjects exhibited similar levels of freezing across trials during the acquisition session. 
Each point in (a) represents the average (±s.e.m.) freezing during the 10-s CS + 20-s trace interval on 
each trial. (b) When tested for retention of fear to the CS the following day, rats which had received 
either of the two higher doses of PACAP6-38 before training exhibited reduced freezing to the CS. Bars 
represent the average (±s.e.m.) freezing for each group. *p < .05, #p = .078 compared with Saline. (c) 
All rats showed intact memory for the context-shock association, which was tested separately from the 
CS memory one day after training. Bars represent the average (±s.e.m.) freezing for each group. (d) 
Spatial working memory was unaffected by PACAP6-38 injection, but was impaired by muscimol 
injection. Bars show the average (±s.e.m.) change in performance from baseline for each injection. 
*p < .05 compared with Saline or PACAP6-38. 
3.2. Experiment 2: prefrontal PAC1R and spatial working memory in females 
Activity in PL is necessary to bridge the stimulus gap in trace conditioning (Gilmartin and 
Helmstetter, 2010, Gilmartin et al., 2013b), a role that may engage working-memory like 
mechanisms. To determine if PACAP6-38 contributes to prefrontal-dependent working memory 
in addition to associative fear learning, PACAP6-38 was administered to rats during a spatial-
working memory paradigm: delayed alternation. Fig. 2d shows the change in performance 
(percentage of correct trials) on injection days compared with the 3-day baseline period before 
any drugs were administered. Muscimol, but not PACAP6-38, produced a significant impairment 
in performance compared with Saline as confirmed by significant post-hoc tests on the main 
effect of Injection (F(2, 20) = 28.513; p = .000001; Cohen's d: 2.48, 0.41, respectively). These 
results suggest that PACAP signaling in the prefrontal cortex does not contribute to working 
memory per se, but does contribute to the acquisition of fear to threat-predictive cues. 
3.3. Experiment 3: prefrontal PAC1R and fear learning in males 
The results of Experiment 1 demonstrate that PAC1R signaling in the PL of female rats 
contributes to the strength of a cued fear memory. Experiment 3 tested whether the same 
effect is observed in male rats. All 40 male rats implanted with bilateral cannulae had 
successful placement in the PL (Fig. 1b). One rat was excluded from all analyses due to tissue 
damage around the cannula site (Saline group). 
Drug administration in males had no effect on freezing during the acquisition session or on the 
formation of the contextual fear memory. All groups acquired fear similarly during acquisition, 
which was confirmed by a lack of a Drug x Trial interaction (ps > 0.18) or Drug main effect 
(ps > 0.37; Fig. 3a). Additionally, PACAP6-38 treatment did not impair the formation of the 
contextual fear memory, as there were no differences between groups during the contextual 
fear retention test the following day (Fig. 3c; ps > 0.30). In contrast to the results in female rats, 
pre-training PACAP6-38 had no reliable effect on the formation of the cued fear memory 
(Fig. 3b). This was supported by the lack of a Drug x Period interaction (ps > 0.10) or Drug 
main effect (2 mM: p = .12; Cohen's d: 0.54; 3 mM: p = .44; Cohen's d: 0.45). These results 
suggest that prefrontal PAC1R signaling plays a role in fear learning in females, but not males. 
 
Fig. 3. PACAP6-38 does not affect learning in males. (a) Subjects in both groups exhibited similar within-
session acquisition of freezing across trials. Each point in (a) represents the average (±s.e.m.) freezing 
during the 10-s CS + 20-s trace interval on each trial. (b) When tested for retention of fear to the CS 
(left panel) and context (right panel) the following day, no differences in freezing were observed. Bars 
represent the average (±s.e.m.) freezing for each group. 
3.4. Sex differences in cued fear memory 
The results of Experiments 1 and 2 raised the question of how females and males differed in 
trace conditioning and in their response to PACAP6-38. We extended our analysis of cue-
elicited freezing in males and females across the entire 5-min CS presentation (Fig. 4) and 
directly compared them in the same analysis. For each sex, rats which had received the 2 or 
3 mM dose of PACAP6-38 were combined into one drug group and compared with Saline 
control rats (females: Saline n = 15; Drug n = 25; males: Saline n = 18; Drug n = 20). Female 
control rats showed sustained freezing that gradually reduced across the 5 min of the CS, with 
drug-treated rats showing consistently less freezing during this time. Male control rats showed 
a more rapid reduction in freezing within the first 3 min, with drug-treated rats showing similar 
levels of fear as controls. This observation was supported by a mixed model ANOVA with both 
Sex and Drug as between factors and Minute (Baseline and 5 CS minutes) as the within factor, 
which revealed a Sex x Drug x Minute interaction (F(5, 370) = 2.575, p < .026). Post-hoc tests 
showed that control females maintained freezing levels significantly above baseline for all 
5 min (ps < 0.001) while control males showed higher-than-baseline levels for the first 2 min 
only (ps < 0.001). Female rats injected with PACAP6-38 showed a significant reduction in 
freezing compared with control females during minutes 2, 3, and 5 of the CS (ps < 0.024). In 
contrast, male rats injected with PACAP6-38 did not differ from control males at any time during 
the CS (p > .09 min 1, ps > 0.12 min 2-5). Indeed, the larger drug effect exhibited by the 
females was confirmed by comparing the relative effect sizes of conditional freezing to the CS 
collapsed across all 5 min (Cohen's d: 0.83 for the females vs. 0.05 for the males). 
 
Fig. 4. PACAP6-38 may reduce the persistence of learned fear in females. (a) Females maintained fear 
expression across all 5 min of the CS test. Each point in (a) represents the average (±s.e.m.) freezing 
during each minute of the 5-min CS presentation. (b) Individual freezing scores (grey diamonds) during 
the first 2 min of the CS are shown for female rats in the Saline and PACAP6-38 groups (2 and 3 mM 
doses combined). Most of the PACAP6-38-treated rats showed a profound reduction in freezing, but a 
subset showed intact fear – an observation that may suggest the presence of individual differences in 
sensitivity to PAC1R disruption within the population of cycling females. (c) Males exhibited a reduction 
in fear within the first 3 min of the CS. (d) Individual freezing scores during the first 2 min of the CS 
show that drug-treated male rats also exhibit variability in CS responding, but similar to that observed in 
control males. *p < .05 compared with Saline. 
We also observed individual differences in the rats' responses to PACAP6-38. Fig. 4 shows the 
distribution of individual freezing scores (panels b and d), averaged across the first 2 min of 
peak fear expression during the CS presentation, for each group of females and males shown 
in Fig. 4a and c. Variability in freezing during the CS was observed in both sexes, but the clear 
bimodal distribution in drug-treated females suggests that an additional factor(s) may mediate 
sensitivity or susceptibility to the fear-reducing effects of blocking endogenous PACAP 
signaling in the prefrontal cortex. As these were cycling females, one possible factor may be 
the relative levels of ovarian hormones prior to training (discussed below). Clearly, this 
variability warrants further scrutiny in future studies. All together our findings suggest that 
PACAP has a sex-specific role in cued fear acquisition. 
3.5. Sex differences in PAC1R mRNA 
The results of Experiment 3 suggest that females are more sensitive to the learning-impairing 
effects of PACAP6-38 in the PL compared with males. Here we tested whether female and male 
rats differ in the expression of PAC1R before or after fear conditioning. RT-qPCR was used to 
quantify the relative expression of PAC1R and PACAP mRNA following training and in 
untrained controls. The estrous cycle of the females was tracked and female rats were 
categorized as High-E2 (n = 9) or Low-E2 (n = 9) based on the predicted estradiol (E2) levels of 
their cycle phase (see Methods). We found no training effect on the expression of PAC1R or 
PACAP mRNA within either sex (ps > 0.55). We therefore combined training and home cage 
groups to look for sex differences in PL mRNA levels with males as the reference group. 
Overall, PAC1R transcripts were significantly greater in females than in males (F(1, 33) = 20.412, 
p < .0001; Cohen's d: 1.58). High-E2 females exhibited the greatest increase in PAC1R 
expression compared with males (Fig. 5). A one-way ANOVA revealed a significant effect of 
Sex (F(2, 32) = 19.830, p < .00001; Cohen's d: 2.23). Post-hoc tests showed that both Low-E2 
and High-E2 females had greater PAC1R expression compared with males (p < .041; Cohen's 
d: 1.16 and p < .00001, Cohen's d: 2.61, respectively) and PAC1R levels in High-E2 females 
were significantly greater than Low-E2 females (p < .002, Cohen's d: 1.36). Since there was no 
difference within either sex between trained and untrained rats, this suggests that PAC1R 
expression in the prelimbic cortex is not dynamically regulated by the fear conditioning 
protocol, but may be dynamically regulated by estradiol. 
 
Fig. 5. Females express greater levels of mRNA for PAC1R compared with males. Each bar shows the 
average (±s.e.m.) mRNA levels expressed as a fold-change relative to male samples for PAC1R (left 
panel) or PACAP (right panel). The prefrontal cortex was extracted from rats 90 min after trace fear 
conditioning or from time-matched home cage controls. Because no training-related differences in 
expression were observed, the data were collapsed within each sex. Females were classified into high 
and low estradiol groups based on their estrous cycle stage at the time of tissue collection. *p < .05. 
There was no effect of training on PACAP mRNA within each sex (ps > 0.56), and as we did for 
our PAC1R analysis, we combined training and home cage groups to examine sex differences 
in PL PACAP mRNA levels using the males as the reference group. There were no differences 
between the sexes in PACAP transcripts overall (F(1, 32) = 3.053, p = .09, Cohen's d: 0.60) and 
no differences between High-E2 and Low-E2 groups (F(2, 31) = 1.510, p = .237, Cohen's d: 0.62). 
However, when considering the entire estrous cycle, the distribution of the data strongly 
suggested that PACAP mRNA levels were elevated during the estrus stage only (mean 
(±s.e.m.) relative expression: Males n = 19, 1.015 (±0.043); Female Estrus n = 7, 1.385 
(±0.157); Female Non-Estrus n = 9, 1.016 (±0.051)). A one-way ANOVA revealed a significant 
effect of cycle stage when comparing males, females in estrus, and females in any other stage 
(F(2, 31) = 6.621, p = .004, Cohen's d: 1.31). Post-hoc tests showed that the females in the estrus 
stage had higher levels of PACAP mRNA compared with males and with females in the other 
stages of the cycle (ps < 0.005, Cohen's ds: > 1.25). Together, this experiment provides 
support for estradiol-mediated PAC1R expression to regulate sensitivity to PACAP signaling in 
an area important for maintaining attention to fear cues. 
4. Discussion 
Administration of the PAC1R antagonist PACAP6-38 directly into the PL dose-dependently 
impaired the formation of associative fear memory. This effect was specific to females and to 
cued fear learning. Females had greater expression of mRNA for the PAC1R in the PL 
compared with males, regardless of training, and expression levels varied with the estrous 
cycle. These results suggest that PACAP signaling in the prefrontal cortex is a means by which 
fear to threat-predictive cues is strengthened in females. This finding provides a potential 
neurobiological substrate for the link between estrogen, a genetic polymorphism in the PAC1R 
gene, and symptom severity in women with PTSD (Mercer et al., 2016, Ressler et al., 2011). 
Pre-training infusion of the PAC1R antagonist into the PL impaired cued fear memory 
formation in females, but not males. Although males did show a slight reduction in freezing 
early in the CS test, the magnitude of the effect was much greater, more statistically reliable, 
and more persistent in females. Females also showed greater expression of mRNA for the 
PAC1 receptor. These results suggest that the prefrontal cortex is a sexually dimorphic site in 
trace fear conditioning: females are more sensitive to the effects of PACAP on emotional 
memory formation in this region. The implication of these observations is that the prefrontal 
cortex may be one site of action for endogenous PACAP that underlies the sex-specific link in 
humans between the PAC1R genetic polymorphism and PTSD. The single-nucleotide 
polymorphism (SNP) rs2267735 in the PAC1R gene in females, but not males, with PTSD 
strongly correlated with the severity of hyperarousal symptoms (Ressler et al., 2011). The SNP 
is found within an estrogen-response element in the promoter region for the PAC1R, and 
Ressler and colleagues recently showed in the BNST and in HEK293T cells that the 
expression of PAC1R mRNA is increased by estradiol (Mercer et al., 2016). In women with 
PTSD, blood levels of PAC1R mRNA positively correlate with estrogen levels (Mercer et al., 
2016). Our quantitative PCR results are consistent with these observations. Females showed 
greater expression of PAC1R mRNA in the PL compared with males, and within the females, 
PAC1R levels were the highest following the peak in estradiol concentrations. This pattern was 
independent of training and suggests that ovarian hormones may regulate the expression of 
PAC1R in the prefrontal cortex. Although the estrous cycle of females was not tracked in the 
behavioral pharmacology experiment, it is plausible that changes in PAC1R expression across 
the estrous cycle contributed to the bimodal response to the PAC1R antagonist in females: the 
majority of the rats showed a strong reduction in cued fear memory, but a subset was 
unaffected by the treatment. By regulating PAC1R expression, ovarian hormones may 
dynamically regulate the sensitivity to PACAP signaling in the PL, which may in turn modulate 
arousal or attention to cues and the strength of fear memory encoding across the estrous 
cycle. A disruption in this dynamic regulation would be expected to lead to aberrant fear 
learning. Indeed, the PAC1R SNP in women with PTSD is associated with impaired cued fear 
discrimination (Ressler et al., 2011). Given that in women with PTSD, PAC1R levels are lower 
in subjects with the SNP than in those with the control alleles and that blood levels of PAC1R 
mRNA are inversely correlated with PTSD symptom severity (Mercer et al., 2016), a reduction 
in PAC1R signaling throughout the brain may contribute to enhanced hyperarousal through 
enhanced stress reactivity and impaired fear learning. Our results suggest that the prefrontal 
cortex is important for PACAP's role in the latter. 
The specificity of our finding to cued fear conditioning compared with contextual fear 
conditioning is consistent with PACAP acting on prefrontal mechanisms of cue encoding or 
plasticity. We have previously shown that a population of cells within the PL exhibits sustained 
firing in response to cues that predict shock, but not to cues that do not predict shock 
(Gilmartin and McEchron, 2005). Specifically, the PL is required for the cue-shock association 
only when the two events are separated in time (Gilmartin and Helmstetter, 2010, Guimarais 
et al., 2011). Using optogenetic silencing of PL cells selectively during this cue-shock trace 
interval, we have shown that prefrontal activity is crucial for cued fear learning (Gilmartin et al., 
2013b). This trace-interval activity may reflect a working-memory or attentional process to 
support associative learning to fear cues (Connor and Gould, 2016, Gilmartin et al., 2014). 
Signaling at PAC1R may contribute to this maintenance signal in females, facilitating the 
association of the cue and subsequent shock. However, the antagonist PACAP6-38 did not 
affect working memory performance in the spatial delayed-alternation task, which suggests 
that PAC1R signaling is not critical for cue maintenance per se. Instead, PAC1R signaling may 
promote the recruitment of cue-related attentional or working memory prefrontal networks 
following an aversive event. Alternatively, PAC1R signaling may facilitate the consolidation of 
the cue-shock memory in the prefrontal cortex, similar to PACAP-enhanced consolidation of 
contextual fear memories in the hippocampus (Schmidt et al., 2015). 
The cellular mechanism by which PAC1R activation promotes associative fear learning in the 
prefrontal cortex is unknown, but one possibility is through facilitation of glutamatergic 
signaling at the GluN2B-containing NMDA receptor. GluN2B-containing NMDA receptors are 
enriched in prefrontal synapses compared with other cortical regions (Wang et al., 2008) and 
because the GluN2B subunit confers a longer deactivation window to the NMDA receptor 
(Cull-Candy and Leszkiewicz, 2004, Monyer et al., 1994), it is able to promote persistent firing 
within prefrontal networks (Wang et al., 2013). Recent work has shown that PACAP enhances 
the phosphorylation of, and thus activity of, GluN2B in hippocampal slices (Yaka et al., 2003) 
and in the ventromedial nucleus of the hypothalamus (VMN) in vivo (Resch et al., 2014). 
Activation of PKA/adenylate cyclase by the PAC1R is thought to mediate this enhancement. 
Moreover, behavioral effects of exogenously administered PACAP can be attenuated by pre-
treatment with the NMDA receptor antagonist APV in the hippocampus (Schmidt et al., 2015) 
or VMN (Resch et al., 2014). Given our previous finding that GluN2B-containing NMDA 
receptors in the PL are important for trace cued, but not contextual fear learning (Gilmartin 
et al., 2013a), it is possible that the selective attenuation of cued fear following the pre-training 
injection of a PAC1R antagonist in this study is a result of reduced activation of GluN2B during 
acquisition. It is important to note that the function of GluN2B in trace conditioning is not 
known. While work in primates suggests that it is necessary for persistent firing in working 
memory (Wang et al., 2013), a recent study by Floresco and colleagues suggests that blocking 
GluN2B activity in the prefrontal cortex does not affect working memory in male rodents (Auger 
and Floresco, 2017). We have also found that injection of the GluN2B antagonist Ro25-6981 
(2 μg/μL; 0.5 μL) into the PL does not affect delayed alternation in female rats (unpublished 
observations; n = 8; F > 1, p > .38). In contrast, Ro25-6981 delivered to the PL does impair 
cued trace, but not contextual, fear conditioning (Gilmartin et al., 2013a). GluN2B in the PL 
may be necessary for PL sustained firing in trace conditioning, but it is also possible that 
GluN2B supports trace conditioning through another mechanism, such as activation of 
intracellular signaling needed for network plasticity or memory consolidation specific to the 
cue-shock association (Gao et al., 2010). It is also possible that the cellular mechanism of 
PAC1R signaling does not involve phosphorylation of GluN2B, but rather involves the 
regulation of synaptic glutamate levels. Recent data suggests that PAC1R is expressed on 
both cortical neurons and astrocytes and can regulate the expression of glial glutamate 
transport systems (Figiel and Engele, 2000, Kong et al., 2016). PAC1R activation may thus 
affect the post-synaptic effects of cue-elicited firing through modulation of extracellular 
glutamate levels. We predict that the behavioral effects of PACAP6-38 in this study are 
mediated by its action at the PAC1R, which we have shown to be present in the PL in both 
sexes and more abundant in females. We cannot completely rule out a role for the vasoactive 
intestinal peptide receptor type-2 (VPAC2R), which is also inhibited by PACAP6-38 (Dickinson 
et al., 1997, Robberecht et al., 1992); however, the adult rodent appears to have little to no 
prefrontal cortical expression of VPAC2R mRNA (Lein et al., 2007 and Experiment 1104 from 
the Allen Brain Atlas: http://mouse.brain-map.org/experiment/show?id = 1104; Sheward et al., 
1995, Usdin et al., 1994). Future studies will determine the source of PACAP released in the 
PL during fear conditioning. We did not observe increases in PL PACAP mRNA as a result of 
training, which leads us to hypothesize that PACAP is primarily released by afferents 
originating in distal regions mediating stress and arousal. 
A role for PAC1R signaling in fear conditioning is consistent with the importance of PACAP in 
adaptive stress responses. PACAP released in the PL during emotional arousal or stress may 
serve to enhance the salience of or attention to cues during associative learning. Disruption of 
PAC1R signaling within frontal cortical regions may thus explain, at least in part, the correlation 
between hyper-reactivity to threat cues in PTSD and the PAC1R genetic polymorphism in 
women. Hyperactivity in the dorsal anterior cingulate of human frontal cortex, which shares 
homology with the rodent PL, is associated with PTSD symptom severity and may even be a 
risk factor for developing PTSD in some patients (Admon et al., 2013, Shin et al., 2011, Shin 
et al., 2009, Shin et al., 2001). PL has several potentially interrelated functions in emotional 
learning that are relevant to PTSD. Not only is the PL necessary for maintaining network 
activity to fear cues during trace conditioning, but it mediates the expression of fear to 
previously learned cues (Burgos-Robles et al., 2009, Corcoran and Quirk, 2007, Gilmartin and 
McEchron, 2005, Gilmartin et al., 2013b, Sierra-Mercado et al., 2010, Vidal-Gonzalez et al., 
2006). Furthermore, the PL is necessary for down-regulating attention to irrelevant or less 
predictive cues as revealed by fear blocking studies (Furlong et al., 2010, Yau and McNally, 
2015). Moreover, the prefrontal cortex is a sexually dimorphic area in the effects of acute 
stress on learning (Maeng and Shors, 2013, Maeng et al., 2010, Wood and Shors, 1998). 
Together, these findings from preclinical and clinical studies suggest that disrupted PACAP 
signaling in the prefrontal cortex has the potential to contribute to exaggerated fear and hyper-
reactivity to threat-predictive cues as well as increased generalization of fear in non-
threatening situations. 
In conclusion, PAC1R signaling in the prefrontal cortex is an exciting new target of study in the 
neurobiological basis of PTSD and the sex differences that contribute to the development and 
maintenance of the disorder. Future work on the interplay of ovarian hormones and PAC1R 
signaling, as well as the identification of downstream effectors of PAC1R activation will be 
instrumental in understanding the conditions in which PACAP exerts its sex-specific effects on 
memory. 
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